These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 19462622)

  • 21. Eradication of bluetongue disease in Germany by vaccination.
    Baetza HJ
    Vet Immunol Immunopathol; 2014 Mar; 158(1-2):116-9. PubMed ID: 24090604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bluetongue vaccines.
    Noad R; Roy P
    Vaccine; 2009 Nov; 27 Suppl 4():D86-9. PubMed ID: 19837295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bluetongue control--a new challenge for Europe.
    Makoschey B; Beer M; Zientara S; Haubruge E; Rinaldi L; Dercksen D; Millemann Y; von Rijn P; de Clercq K; Oura C; Saegerman C; Domingo M; Sanchez-Vizcaino JM; Mehlhorn H; Tamba M; Thiry E
    Berl Munch Tierarztl Wochenschr; 2008; 121(7-8):306-13. PubMed ID: 18712267
    [No Abstract]   [Full Text] [Related]  

  • 24. Protective duration of immunity of an inactivated bluetongue (BTV) serotype 2 vaccine against a virulent BTV serotype 2 challenge in sheep.
    Hamers C; Rehbein S; Hudelet P; Blanchet M; Lapostolle B; Cariou C; Duboeuf M; Goutebroze S
    Vaccine; 2009 May; 27(21):2789-93. PubMed ID: 19366576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of bluetongue vaccine in Scotland.
    Bartram D
    Vet Rec; 2008 Nov; 163(21):638. PubMed ID: 19029114
    [No Abstract]   [Full Text] [Related]  

  • 26. Laboratory evaluation of a living attenuated vaccine against bluetongue type 20 virus.
    Wark MC; Shepherd-Clark MB; Smith HV; Collins WD
    Aust Vet J; 1982 Jul; 59(1):6-10. PubMed ID: 6293439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endophily in Culicoides associated with BTV-infected cattle in the province of Limburg, south-eastern Netherlands, 2006.
    Meiswinkel R; Goffredo M; Dijkstra EG; van der Ven IJ; Baldet T; Elbers A
    Prev Vet Med; 2008 Oct; 87(1-2):182-95. PubMed ID: 18672304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Financial consequences of the Dutch bluetongue serotype 8 epidemics of 2006 and 2007.
    Velthuis AG; Saatkamp HW; Mourits MC; de Koeijer AA; Elbers AR
    Prev Vet Med; 2010 Mar; 93(4):294-304. PubMed ID: 19962204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bluetongue control in Europe--new challenges and achievements.
    Makoschey B; Maclachlan J; v Wuijckhuise L; Kirschvink N; dal Pozzo F; Petit H; Kaandorp-Huber C; v Rijn P; Sellal E; Oura C; Boinas F; Cavirani S; de Clercq K; Lucientes J; Meijjes CP; Zientara S; Meyer G; Thiry E
    Berl Munch Tierarztl Wochenschr; 2009; 122(7-8):314-24. PubMed ID: 19681404
    [No Abstract]   [Full Text] [Related]  

  • 30. The Culicoides 'snapshot': a novel approach used to assess vector densities widely and rapidly during the 2006 outbreak of bluetongue (BT) in The Netherlands.
    Meiswinkel R; Goffredo M; Leijs P; Conte A
    Prev Vet Med; 2008 Oct; 87(1-2):98-118. PubMed ID: 18657871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Did vaccination slow the spread of bluetongue in France?
    Pioz M; Guis H; Pleydell D; Gay E; Calavas D; Durand B; Ducrot C; Lancelot R
    PLoS One; 2014; 9(1):e85444. PubMed ID: 24465562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of three inactivated vaccines against bluetongue virus serotype 8 in sheep.
    Eschbaumer M; Hoffmann B; König P; Teifke JP; Gethmann JM; Conraths FJ; Probst C; Mettenleiter TC; Beer M
    Vaccine; 2009 Jun; 27(31):4169-75. PubMed ID: 19406189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness and cost-benefit study to encourage herd owners in a cost sharing vaccination programme against bluetongue serotype-8 in Belgium.
    Cargnel M; Van der Stede Y; Haegeman A; De Leeuw I; De Clercq K; Méroc E; Welby S
    Transbound Emerg Dis; 2019 Jan; 66(1):400-411. PubMed ID: 30281942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Bluetongue virus present in many milk cows].
    Tijdschr Diergeneeskd; 2008 May; 133(10):440. PubMed ID: 18561708
    [No Abstract]   [Full Text] [Related]  

  • 35. Potency and efficacy of inactivated bluetongue virus vaccines.
    Stevens DR; Stott J; Osburn BI; Giles R; Wiesehahn GP; Barber TL
    Prog Clin Biol Res; 1985; 178():649-52. PubMed ID: 2989914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of efficacy of a bivalent BTV-2 and BTV-4 inactivated vaccine by vaccination and challenge in cattle.
    Savini G; Hamers C; Conte A; Migliaccio P; Bonfini B; Teodori L; Di Ventura M; Hudelet P; Schumacher C; Caporale V
    Vet Microbiol; 2009 Jan; 133(1-2):1-8. PubMed ID: 18617335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Review of the 1995 vesicular stomatitis outbreak in the western United States.
    Bridges VE; McCluskey BJ; Salman MD; Hurd HS; Dick J
    J Am Vet Med Assoc; 1997 Sep; 211(5):556-60. PubMed ID: 9290819
    [No Abstract]   [Full Text] [Related]  

  • 38. A study on bluetongue virus infection in Saudi Arabia using sentinel ruminants.
    Abu Elzein EM; Aitchison H; al-Afaleq AI; al-Bashir AM; Ibrahim AO; Housawi FM
    Onderstepoort J Vet Res; 1998 Dec; 65(4):243-51. PubMed ID: 10192836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccines for bluetongue and other orbiviruses from a regulatory viewpoint.
    Strating A
    Prog Clin Biol Res; 1985; 178():627-9. PubMed ID: 2989911
    [No Abstract]   [Full Text] [Related]  

  • 40. Why German farmers have their animals vaccinated against Bluetongue virus serotype 8: results of a questionnaire survey.
    Gethmann J; Zilow V; Probst C; Elbers AR; Conraths FJ
    Vaccine; 2015 Jan; 33(1):214-21. PubMed ID: 25454856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.